[1]曹雪 蒲秀玲 刘小莹 彭红侠 郭团茂 张晓妮.陕西咸阳地区新型冠状病毒肺炎患者中医临床特征分析[J].陕西中医药大学学报,2021,44(04):001-4.[doi:10.13424/j.cnki.jsctcm.2021.04.001]
　CAO Xue PU Xiuling LIU Xiaoying PENG Hongxia GUO Tuanmao ZHANG Xiaoni.Clinical Characteristics of COVID-19 Patientsin Xianyang District of Shaanxi[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):001-4.[doi:10.13424/j.cnki.jsctcm.2021.04.001]
点击复制

陕西咸阳地区新型冠状病毒肺炎患者 中医临床特征分析
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
44
期数:
2021年04期
页码:
001-4
栏目:
疫病防治
出版日期:
2021-07-30

文章信息/Info

Title:
Clinical Characteristics of COVID-19 Patients in Xianyang District of Shaanxi
文章编号:
2096-1340(2021)04-0001-04
作者:
曹雪 蒲秀玲 刘小莹 彭红侠 郭团茂 张晓妮
咸阳市中心医院，陕西 咸阳 712000
Author(s):
CAO Xue PU Xiuling LIU Xiaoying PENG Hongxia GUO Tuanmao ZHANG Xiaoni
Xianyang Central Hospital，Shaanxi Xianyang 712000，China
关键词:
新冠肺炎; 中医临床; 寒湿郁肺; 咸阳
Keywords:
COVID-19;  TCM clinic;  Cold dampness stagnates the lung;  Xianyang
分类号:
R259
DOI:
10.13424/j.cnki.jsctcm.2021.04.001
文献标志码:
A
摘要:
目的 分析陕西咸阳地区新冠肺炎患者临床特征，尤其是中医临床特征，为该病的防治提供科学依据。方法 以2020年1月21日—2020年3月4日我院收治的17例新冠肺炎患者为研究对象，收集、分析患者的一般情况、中医临床特征信息、血液生化指标检测、肺部CT情况，并依据《新型冠状病毒感染的肺炎诊疗方案（试行第四、五版）》进行辨证。结果 17例患者中发病年龄较大，男性居多，多有湖北地区旅居史和与确诊患者密切接触史，普通型多见（82.35%）；白细胞总数、淋巴细胞计数多正常、C反应蛋白和血清淀粉样蛋白多升高，94.12%的患者肺部病变明显而双肺者为64.71%、单肺病变及斑片状渗出各占58.82%；首发症状以发热为主（76.47%）；中医临床特征有发热（82.35%）、咽干（76.47%）、倦怠乏力（70.59%）、咳嗽（64.71%）、恶心呕吐、舌淡红（均52.94%），舌腻（88.24%）、濡脉（76.47%）等，证型以寒湿郁肺为主（94.12%）。结论 本病传染性强，传变迅速，初期病位主在肺脏，累及脾胃，寒湿郁肺型常见。
Abstract:
Objective To analyze COVID-19 in Shaanxi Xianyang area，especially the clinical characteristics of TCM，and provide scientific basis for prevention and treatment of this disease.Methods 17 patients with COVID-19 admitted in our hospital from January 21，2020 to March 4，2020 were selected as the subjects.The general situation，clinical characteristics，blood biochemical indices and CT of lung were collected and analyzed，and the syndrome was diagnosed according to the diagnosis and treatment plan of COVID19 infection (trial version fourth，fifth).Results Among the 17 patients，the age of onset was older，most of them were male，most of them had the history of living in Hubei area and close contact with the diagnosed patients，and the common type was more common (82.35%); The total number of white blood cells and lymphocyte count were more normal，C-reactive protein and serum amyloid protein were more increased.94.12% of the patients had obvious lung lesions，while 64.71% of the patients had bilateral lung lesions.Single lung lesions and patchy exudation accounted for 58.82% respectively; The first symptom was fever (76.47%); The clinical features of TCM included fever (82.35%)，dry throat (76.47%)，fatigue (70.59%)，cough (64.71%)，nausea and vomiting，redness of tongue (52.94%)，greasy fur (88.24%) and moistening pulse (76.47%)，etc.The main syndrome type was cold dampness stagnation of lung (94.12%).Conclusion The disease is highly infectious and spreads rapidly.In the early stage，the main location of the disease is in the lung，involving the spleen and stomach.

参考文献/References:

［1］国家卫生健康委员会.新型冠状病毒肺炎诊疗方案（试行第六版）［EB/OL］(2020-02-18)［2020-02-20］.http://www.satcm.http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
［2］国家卫生健康委员会.新型冠状病毒肺炎诊疗方案（试行第七版）［EB/OL］(2020-03-3)［2020-03-4］.http://www.satcm.http://www.nhc.gov.cn/yzygj/s7653p/202003/ 46c9294a7dfe4cef80dc7f5912eb1989.shtml.
［3］咸阳市卫生健康委员.截至２月21日２４时新型冠状病毒感染的肺炎疫情最新情况［EB/OL］.(2020-02-21)［2020-02-22］.http://wjj.xys.gov.cn/xwdt/wjyw/707106.htm.
［4］国家卫生健康委员会.关于印发新型冠状病毒感染的肺炎诊疗方案（试行第四版）［EB/OL］(2020-01-27)［2020-01-28］.http://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b43209b31739bd0785e67.shtml.
［5］国家卫生健康委员会.关于印发新型冠状病毒感染的肺炎诊疗方案（试行第五版）［EB/OL］(2020-02-05)［2020-02-05］.http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b4204a79db5b8912d4440.shtml.
［6］张登本.中医学基础［M］.北京：中国中医药出版社,2017.
［7］马健.温病学［M］.上海：上海科技出版社,2008：14.
［8］韩雪梅.论温疫学派学术特色在SARS治疗中的作用［J］.河南中医，2003,23(12):14-15.
［9］吴宇峰，于琦,王燕平，等.中医温疫类疾病认识的继承与发展［J］.中国中医基础医学杂志,2013,19(7):736738.
［10］郑榕,陈琴,黄铭涵.从“寒湿疫毒”辨治新型冠状病毒感染肺炎［J／OL］.中国中医药信息杂志.（2020-02-13）［2020-02-18］.http://kns.cnki.net/kcms/detail/11.3619.r.20200213.2205.002.html.
［11］范逸品，王燕平，张华敏，等.试析从寒疫论治新型冠状病毒（2019-NCOV）感染的肺炎［J／OL］.中医杂志.（2020-02-06）［2020-02-18］.http://kns.cnki.net/kcms/detail/11.2166Ｒ.20200６.1519.007.html.
［12］冯全生,张之文.传承瘟疫学理论,构建中医疫病防治新体系［J］.成都中医药大学学报,2009,32(4)：11-13.
［13］叶天士.温热论［M］.北京：人民卫生出版社，2007：18.
［14］黄帝内经素问校释［M］.北京：人民卫生出版社，2006：489.
［15］吴又可.瘟疫论［M］.于伯海.伤寒金匮温病名著集成.北京：华夏出版社，1997：668.
［16］薛生白.湿热论［M］.北京：人民卫生出版社，2007：47.
［17］LI Q，GUAX,WU P,et al.Early Transmission Dynamics in Wuhan,china,of Nowel coronaviruslnfected Pneumonia［J］.N Engl J Med,2020.
［18］王玉光，齐文升，马家驹，等.新型冠状病毒（2019nCoV）肺炎中医临床特征与辨证治疗初探［J］.中医杂志，2020，61（4）：281-285.
［19］HUANG C，WANG Y，LI X,et al CIinical features of patients infected with 2019 novel coronavirus in Wuhan,China［J］.Lancet，2020.
［20］张侠，李柳，戴广川，等.南京地区42例新型冠状病毒肺炎临床特征及中医症候初探［J/OL］.南京中医药大学学报.(2020-02-18)［2020-02-19］.http://kns.cnki.net/kcms/detail/32.1247.r.20200219.0801.002.html.

相似文献/References:

[1]杨璞叶,黄小正,杨明博,等.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(预出版):024.
　Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):024.
[2]魏耕树 朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(预出版):036.
　Gengshu Wei,Enlin Zhu,Xin Wang,et al.Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):036.
[3]赵晓平 昝强 范小璇** 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式**[J].陕西中医药大学学报,2020,(预出版):061.
　Xiaoping Zhao,Qiang Zan,Xiaoxuan Fan*,et al.Follow the Pattern of 4+4 to Prevention and Control Novel Coronavirus Pneumonia(NCP) in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):061.
[4]赵晓平 昝强 范小璇 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式[J].陕西中医药大学学报,2020,(02):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
　Zhao Xiaoping,Zan Qiang,Fan Xiaoxuan,et al.The 4 +4 Pattern to Prevent and Control Coronavirus Disease 2019 in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
[5]杨璞叶 黄小正 杨明博 张鑫.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(03):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
　Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
[6]魏耕树朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(5):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
　Wei Gengshu,Zhu Enlin,Wang Xin,et al.Feasibility of Yiqi Xuanbi Decoction in the Treatment of Post - Covid19 Pulmonary Fibrosis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
[7]崔晋伟 张晓梅,杨华升 赖宇鑫 刘彧杉 于小林 姜良铎.姜良铎从急性虚损辨治新型冠状病毒肺炎探讨[J].陕西中医药大学学报,2021,44(01):010.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
　CUI Jin - wei,ZHANG Xiao - mei,YANG Hua - sheng,et al.Discussion on the Treatment of COVID-19 from the Pespective of Acute Insufficiency Differentiation Syndrome by JIANG Liang-duo[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):010.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
[8]康艳 李耀辉** 薛敬东 刘伊莎.基于脏腑相关理论之肺脾相关分析新冠肺炎的病位[J].陕西中医药大学学报,2021,44(03):005.[doi:10.13424/j.cnki.jsctcm.2021.03.002]
[9]毛娅 崔翔 王晓玲 刘运磊 吴倩张洁.安康地区26例普通型新冠病毒肺炎患者恢复期中医辨治体会[J].陕西中医药大学学报,2021,44(04):005.[doi:10.13424/j.cnki.jsctcm.2021.04.002]
　MAO Ya CUI XiangWANG Xiaoling LIU YunleiWU Qian ZHANG Jie.Experience in Treating 26 cases of CommonCOVID-19 Patients in Convalescence in Ankang area[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):005.[doi:10.13424/j.cnki.jsctcm.2021.04.002]
[10]王凤霞 张云 李晓彬 侯海荣 刘可春.小青龙汤用于新冠肺炎患者救治可行性分析[J].陕西中医药大学学报,2021,44(04):011.[doi:10.13424/j.cnki.jsctcm.2021.04.003]

备注/Memo

备注/Memo:
基金项目：陕西省2020年度中医药防治新冠肺炎项目（2020-YJ004）
更新日期/Last Update: 2021-07-30